Co-immunization with spike and nucleocapsid based DNA vaccines for long-term protective immunity against SARS-CoV-2 Omicron

Co-immunization with spike and nucleocapsid based DNA vaccines for long-term protective immunity against SARS-CoV-2 Omicron

Abstract The continuing evolution of SARS-CoV-2 variants challenges the durability of existing spike (S)-based COVID-19 vaccines. We hypothesized that vaccines composed of both S and nucleocapsid (N) antigens would increase the durability of protection by strengthening and broadening cellular immuni...

Full description

Saved in:

Bibliographic Details
Main Authors:	Paolla Beatriz Almeida Pinto, Julia Timis, Kantinan Chuensirikulchai, Qin Hui Li, Hsueh Han Lu, Erin Maule, Michael Nguyen, Rúbens Prince dos Santos Alves, Shailendra Kumar Verma, Fernanda Ana-Sosa-Batiz, Kristen Valentine, Sara Landeras-Bueno, Kenneth Kim, Kathryn Hastie, Erica Ollmann Saphire, Ada Alves, Annie Elong Ngono, Sujan Shresta
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-12-01
Series:	npj Vaccines
Online Access:	https://doi.org/10.1038/s41541-024-01043-3
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Induction of Humoral and Cellular Immunity by Intradermal Delivery of SARS-CoV-2 Nucleocapsid Protein Using Dissolvable Microneedles
by: Chaiyaporn Kuwentrai, et al.
Published: (2021-01-01)

A core network in the SARS-CoV-2 nucleocapsid NTD mediates structural integrity and selective RNA-binding
by: Karthikeyan Dhamotharan, et al.
Published: (2024-12-01)

Identification of G-quadruplex-forming Sequences in Nucleocapsid Gene of SARS-CoV-2 Variants of Concern: An In Silico Analysis
by: Saeedeh Ghazaey Zidanloo
Published: (2024-02-01)

Obtaining HBV core protein VLPs carrying SARS-CoV-2 nucleocapsid conserved fragments as vaccine candidates
by: Yadira Lobaina, et al.
Published: (2024-11-01)

Co-evolution of glioma and immune microenvironment
by: Jacob S Young, et al.
Published: (2024-12-01)

Detrimental Effects of Anti-Nucleocapsid Antibodies in SARS-CoV-2 Infection, Reinfection, and the Post-Acute Sequelae of COVID-19
by: Emi E. Nakayama, et al.
Published: (2024-12-01)

Comparative evaluation of cell-based assay technologies for scoring drug-induced condensation of SARS-CoV-2 nucleocapsid protein
by: Rui Tong Quek, et al.
Published: (2025-03-01)

Immunoreactivity Analysis of MHC-I Epitopes Derived from the Nucleocapsid Protein of SARS-CoV-2 via Computation and Vaccination
by: Dongbo Jiang, et al.
Published: (2024-10-01)

Genomic sequencing and neutralizing serological profiles during acute dengue infection: A 2017 cohort study in Nepal
by: Sabita Prajapati, et al.
Published: (2024-01-01)

Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions—United States, 2020–2022
by: Anna Bratcher, et al.
Published: (2025-01-01)

Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions-United States, 2020-2022.
by: Anna Bratcher, et al.
Published: (2025-01-01)

SARS-CoV-2 nucleocapsid protein interaction with YBX1 displays oncolytic properties through PKM mRNA destabilization
by: Xin Chen, et al.
Published: (2024-11-01)

Coronavirus nucleocapsid protein enhances the binding of p-PKCα to RACK1: Implications for inhibition of nucleocytoplasmic trafficking and suppression of the innate immune response.
by: Wenxiang Xue, et al.
Published: (2024-11-01)

High prevalence of undocumented SARS-CoV-2 infections revealed by analysis of nucleocapsid-specific IgG responses in diagnosed and undiagnosed individuals.
by: Kim Blom, et al.
Published: (2025-01-01)

Immune Response Against SARS-CoV-2
by: Angela Stufano, et al.
Published: (2024-12-01)

The immune landscape and viral shedding of Omicron SARS-CoV-2 variants implicate immune escape
by: Weilong Zhang, et al.
Published: (2025-01-01)

Distribution of bacterial DNA repair proteins and their co-occurrence with immune systems
by: Sumanth K. Mutte, et al.
Published: (2025-01-01)

Co-Amoxiclav Induced Immune Haemolytic Anaemia: A Case Report
by: H. G. C. S. Karunathilaka, et al.
Published: (2020-01-01)

The R203M and D377Y mutations of the nucleocapsid protein promote SARS-CoV-2 infectivity by impairing RIG-I-mediated antiviral signaling.
by: Yongkui Li, et al.
Published: (2025-01-01)

Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy following mRNA SARS-CoV-2 Vaccination
by: Marta Rodrigues de Carvalho, et al.
Published: (2023-01-01)

Advances in Cell and Immune Therapies for Melanoma
by: Tanase Timis, et al.
Published: (2025-01-01)

Microdetection of Nucleocapsid Proteins via Terahertz Chemical Microscope Using Aptamers
by: Xue Ding, et al.
Published: (2024-11-01)

Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses
by: Rafael Bayarri-Olmos, et al.
Published: (2024-12-01)

Reduced durability of hybrid immunity to SARS-CoV-2 in immunocompromised children
by: Youjia Zhong, et al.
Published: (2024-12-01)

Co-dynamics of hepatitis B and C viruses under the influence of CTL immunity
by: A.M. Elaiw, et al.
Published: (2025-04-01)

Inhibition of Endosomal Transport Results in Decreased Synthesis of Nucleocapsid Protein of PHV Virus
by: M. Muyangwa, et al.
Published: (2017-03-01)

Editorial: Immune studies of SARS-CoV2 and vaccines using preclinical modeling
by: Cordelia Dunai, et al.
Published: (2025-01-01)

RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2
by: Rang Feng, et al.
Published: (2025-02-01)

Cattle, sheep, and goat humoral immune responses against SARS-CoV-2
by: Mehrnaz Ardalan, et al.
Published: (2024-12-01)

Sindbis Virus Replicon-Based SARS-CoV-2 and Dengue Combined Vaccine Candidates Elicit Immune Responses and Provide Protective Immunity in Mice
by: Yihan Zhu, et al.
Published: (2024-11-01)

Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer
by: Lukas Klein, et al.
Published: (2025-01-01)

Strategies Used by SARS-CoV-2 to Evade the Innate Immune System in an Evolutionary Perspective
by: Hong Fan, et al.
Published: (2024-12-01)

Deciphering Immune Modulation in Chickens Co-Infected with ALV-J and CIAV: A Transcriptomic Approach
by: Sheng Chen, et al.
Published: (2024-11-01)

SARS-CoV-2 immune responses in patients with multiple myeloma and lenalidomide maintenance therapy
by: Ioana Martac, et al.
Published: (2024-12-01)

Impact of SARS-CoV-2 vaccination and of seasonal variations on the innate immune inflammatory response
by: Hend Jarras, et al.
Published: (2025-01-01)

Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion.
by: Harriet V Mears, et al.
Published: (2025-01-01)

SARS-CoV-2 vaccine-elicited immune responses in solid organ transplant recipients
by: Euri Seo, et al.
Published: (2024-12-01)

SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity
by: Jianfeng Zhou, et al.
Published: (2020-10-01)

RNA editing regulates host immune response and T cell homeostasis in SARS-CoV-2 infection.
by: Molly Huang, et al.
Published: (2024-01-01)

Case report: Treatable immune-mediated severe orthostatic hypotension in SARS-CoV-2 infection
by: Kenji Theiler, et al.
Published: (2025-01-01)